LyondellBasell (LYB) Q1 2026 Earnings Preview: Seeking Signs of Stabilization
Key Takeaways
- Analysts expect LYB to report first-quarter 2026 EPS of about $0.28-$0.31, a rebound from Q4 2025's loss of $0.26 per share.
- Revenue consensus stands at approximately $7.37 billion, down slightly year-over-year due to softer chemical pricing.
- Key focus on Olefins & Polyolefins (O&P) segment margins amid global oversupply and weak demand.
- Company's cash improvement plan targets $1.3 billion by end-2026, supporting dividend stability.
- Trailing earnings surprises average negative 63.8%, raising bar for positive reaction.
- EBITDA (earnings before interest, taxes, depreciation, and amortization) expectations hinge on cost controls and volume stability.
Why LYB's Q1 2026 Earnings Matter
LyondellBasell Industries, one of the world's leading chemicals producers, is approaching its first-quarter 2026 earnings report at a critical juncture. Following a full-year 2025 net loss of $738 million—largely due to compressed margins and petrochemical oversupply—investors are looking for evidence of a turnaround. The company's diversified operations across O&P, Advanced Polymer Solutions, and refining give it potential exposure to recovering demand in packaging and durable goods. In my view, this report carries weight because it could highlight progress on the $1.3 billion cash improvement plan, shaping sentiment in an industry strained by overcapacity and economic headwinds. Positive outcomes here might reinforce LYB's appeal through its attractive dividend yield for income-focused investors.
Consensus Expectations for the Quarter
Wall Street forecasts point to Q1 2026 revenue of $7.37 billion for LyondellBasell, a slight dip from $7.677 billion in the prior-year quarter, mainly from lower average selling prices even as volumes hold steady. The consensus EPS estimate sits at $0.28, drawn from 15 analysts—a marked improvement over Q4 2025's $0.26 loss per share, though still trailing Q1 2025's $0.33 excluding identified items.
One area I'll be watching closely is EBITDA, projected in the $500-600 million range when adjusting historical trends for today's environment, along with segment breakdowns. Margins in the O&P segment will draw particular scrutiny given the ethylene and propylene glut. Updates on 2026 capex around $1.2 billion and ongoing cost savings will also matter. LYB has a recent track record of missing EPS targets, as seen in Q4 2025's -$0.26 actual versus $0.22 expected, yet the stock climbed afterward on hopes of recovery. Post-earnings moves have typically been volatile, often +5-10% on beats.
Market Sentiment Heading In
Sentiment toward LYB remains cautiously optimistic ahead of this release, with the Earnings Surprise Prediction (ESP) metric at +10.28% hinting at a possible beat. The shares demonstrated resilience after Q4's miss, supported by expectations around cost reductions. That said, risks linger from softer demand in Europe and China, as well as fluctuating energy costs. Options activity suggests an 8-10% swing post-earnings, consistent with past patterns. With peers in the chemicals sector under similar strain, much attention will fall on LYB's guidance.
Leveraging Tickeron’s AI Screener in My Analysis
In my research process, I often turn to Tickeron’s AI Screener, an AI-driven tool that lets me sift through stocks and ETFs using technical patterns, fundamentals, trends, volatility, and predictive signals. It scans thousands of names with filters for industry peers, market cap, indicators, price patterns, and metrics, surfacing ideas like breakout candidates or value plays far quicker than manual methods. For instance, I used it here to gauge how LYB stacks up against chemical sector peers—it's a straightforward way to spot relative opportunities and refine my outlook.
Looking Ahead: Key Factors to Track
Once the numbers are out, management's take on 2026 demand trends will take center stage. Petrochemical oversupply looks set to linger through mid-year, though potential supply disruptions might widen O&P spreads. Demand for oxyfuels, linked to refining operations, continues as a positive amid stable gasoline use.
Progress on the $1.3 billion cash generation target by year-end remains crucial, covering $1.2 billion in capex while sustaining the adjusted dividend. I'll also monitor margin gains in Intermediates & Derivatives from disciplined cost management.
On the bigger picture, advancements in U.S. Gulf Coast projects and sustainability efforts could provide tailwinds amid evolving regulations. Industry-wide chemical production growth of 1-3% supports the case, but global economic signals around packaging and construction will be telling. Strong execution on these fronts could set LYB up for better full-year results.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
LYB's RSI Indicator is sitting in oversold zone for 6 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .
LYB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LYB entered a downward trend on June 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.881) is normal, around the industry mean (7.510). P/E Ratio (98.766) is within average values for comparable stocks, (43.938). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (72.226). LYB's Dividend Yield (0.070) is considerably higher than the industry average of (0.021). P/S Ratio (0.635) is also within normal values, averaging (93.443).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LYB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of petrochemicals
Industry ChemicalsSpecialty
Advertisement